TG THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
TG THERAPEUTICS, INC. (TGTX) reported Earnings Per Share, Basic and Diluted of -$2.63 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-01
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.65.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.59.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.69.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.73.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.63.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$2.42.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.96.
- TG THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.30.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$2.63 10-K · filed 2022-03-01 | |||||||
| 2021-09-30 | -$0.65 10-Q · filed 2021-11-08 | -$1.93 10-Q · filed 2021-11-08 | ||||||
| 2021-06-30 | -$0.59 10-Q · filed 2021-08-06 | -$1.28 10-Q · filed 2021-08-06 | ||||||
| 2021-03-31 | -$0.69 10-Q · filed 2021-05-10 | |||||||
| 2020-12-31 | -$2.42 10-K · filed 2022-03-01 | |||||||
| 2020-09-30 | -$0.73 10-Q · filed 2021-11-08 | -$1.70 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | -$0.47 10-Q · filed 2021-08-06 | -$0.95 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | -$0.48 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | -$0.44 10-K · filed 2020-03-02 | -$1.96 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | -$0.69 10-Q · filed 2020-11-09 | -$1.55 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | -$0.42 10-Q · filed 2020-08-10 | $0.42 10-Q · filed 2019-08-09 | -$0.85 10-Q · filed 2020-08-10 | $0.85 10-Q · filed 2019-08-09 | ||||
| 2019-03-31 | -$0.43 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | -$0.68 10-K · filed 2020-03-02 | -$2.30 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$0.43 10-K · filed 2020-03-02 | -$1.61 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$0.59 10-K · filed 2020-03-02 | $1.18 10-Q · filed 2019-08-09 | -$1.18 10-Q · filed 2018-08-09 | |||||
| 2018-03-31 | -$0.59 10-K · filed 2020-03-02 | |||||||
| 2017-12-31 | -$0.46 10-K · filed 2019-03-01 | -$1.91 10-K · filed 2020-03-02 | ||||||
| 2017-09-30 | -$0.48 10-K · filed 2019-03-01 | -$1.45 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | -$0.45 10-K · filed 2019-03-01 | -$0.96 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$0.52 10-K · filed 2019-03-01 | |||||||
| 2016-12-31 | -$0.48 10-K · filed 2018-03-15 | -$1.60 10-K · filed 2019-03-01 | ||||||
| 2016-09-30 | -$0.50 10-K · filed 2018-03-15 | -$1.11 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | -$0.33 10-K · filed 2018-03-15 | -$0.61 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | -$0.28 10-K · filed 2018-03-15 | |||||||
| 2015-12-31 | -$0.37 10-K · filed 2017-03-16 | -$1.38 10-K · filed 2018-03-15 | ||||||
| 2015-09-30 | -$0.28 10-K · filed 2017-03-16 | -$1.01 10-Q · filed 2016-11-09 | ||||||
| 2015-06-30 | -$0.38 10-K · filed 2017-03-16 | -$0.73 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$0.35 10-K · filed 2017-03-16 | |||||||
| 2014-12-31 | -$0.48 10-K · filed 2016-03-15 | -$1.64 10-K · filed 2017-03-16 | ||||||
| 2014-09-30 | -$0.51 10-K · filed 2016-03-15 | -$1.14 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | -$0.36 10-K · filed 2016-03-15 | -$0.62 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$0.25 10-K · filed 2016-03-15 | |||||||
| 2013-12-31 | -$0.81 10-K · filed 2016-03-15 | |||||||
| 2013-09-30 | -$0.16 10-Q · filed 2014-11-14 | -$0.62 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | -$0.29 10-Q · filed 2014-07-24 | -$0.46 10-Q · filed 2014-07-24 | ||||||
| 2013-03-31 | -$0.17 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | -$1.38 10-K · filed 2014-03-07 | |||||||
| 2012-09-30 | -$0.16 10-Q · filed 2013-11-14 | -$1.34 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | -$0.16 10-Q · filed 2013-08-09 | -$1.44 10-Q · filed 2013-08-09 | ||||||
| 2012-03-31 | -$2.03 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | -$0.44 10-K · filed 2013-03-21 | $0.00 10-K · filed 2012-03-14 | ||||||
| 2011-09-30 | -$0.01 10-Q · filed 2012-11-14 | -$0.16 10-Q · filed 2011-11-14 | -$1.59 derived: net income ÷ weighted average shares · filed 2012-11-14 | -$0.21 10-Q · filed 2012-11-14 | $0.10 10-Q · filed 2011-11-14 | |||
| 2011-06-30 | -$0.15 10-Q/A · filed 2012-09-07 | -$1.15 10-Q/A · filed 2011-09-14 | -$0.31 10-Q/A · filed 2012-09-07 | $0.33 10-Q/A · filed 2011-09-14 | ||||
| 2010-09-30 | $0.02 10-Q · filed 2011-11-14 | $0.12 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | $0.77 10-Q/A · filed 2011-09-14 | $0.11 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |